The Middle-East & Africa animal vaccines market is poised to reach $455.17 Million by 2020 from $348.61 Million in 2015, at a CAGR of 5.48% from 2015 to 2020. Veterinary Vaccines are important and, at times, essential tools for prevention or control of a given animal disease, but they require complementary actions like enabling legislation, investment for diagnostic, early response, public communication etc.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/292962 .
The growing demand for livestock products (fuelled by population growth, increased urbanisation and greater purchasing power of individuals in developing or middle- income countries) coupled with the necessity of complying with the standards of trade agreements, mean that governments in the Middle-East & Africa region must improve animal health in their countries.
Veterinary vaccine market has shown significant growth in recent years which can be attributed to increasing incidences of animal pandemics in the region. Contagious bovine pleuropneumonia is endemic in numerous areas of Africa, and is suspected to occur occasionally in the Middle East. Rift Valley fever (RVF) is an insect-borne, multi-species zoonotic viral disease of livestock has been exclusively con?ned to the African continent, but it began spreading to Middle-East in the past decade. This marks the estimation of further growth in the market in terms of livestock vaccine sales. However, International and regional collaboration has proven successful in the progressive control of these pandemics, e.g. the work of the Pan American Foot-and-Mouth Disease Centre in South America and the European Union FMD Commission which this region lacks. It makes adoption of regulations that much harder in the area. Rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.
Browse the full report @ http://www.orbisresearch.com/reports/index/middle-east-and-africa-veterinary-vaccines-market-by-type-by-technology-and-by-region-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021 .
The Middle-East & Africa veterinary vaccines market has been categorized as livestock and companion vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. Furthermore, on the basis of geography, the Middle-East & Africa Market is analysed under major regions of Middle-East and Africa.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/292962 .
Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For more information contact email@example.com